MRO Magazine

SLIPS Technologies Expands Commercial Deployment after Successful 2015 Product Rollouts


January 20, 2016
By Business Wire News

CAMBRIDGE, Mass.

SLIPS Technologies, Inc., manufacturer of the SLIPS™ family of fully-slippery materials and coatings that repel virtually all fluids and biological fouling agents, concluded its first year of operations with alpha products deployed to solve sticky surface problems in industrial, medical, and consumer applications.

SLIPS™ films are currently installed on glass in a Manhattan skyscraper to help prevent ice build-up, a well-known hazard for pedestrians below. SLIPS™ coatings are being field tested to alleviate marine fouling attachment on ships – a costly sticky problem that causes extra drag and wastes $20 billion in fuel annually. Clinicians at a major teaching hospital in Boston are using SLIPS™-coated scopes to prevent blood and mucus buildup thus maintaining clear vision inside patient bodies. Medical device companies are evaluating SLIPS™ for use in catheters and stents as a way to prevent bacterial adhesion and other biological fouling. One of the world’s largest consumer products companies is using SLIPS™ to improve the functionality of a global product line. Industrial customers are evaluating SLIPS™-coated containers and process equipment to help release viscous liquids from surfaces, thus reducing waste, clean-up requirements, and manufacturing inefficiencies.

To support and expand its commercial development of SLIPS™, the company aims to raise a $7.5m Series B during the first half of 2016. CEO Daniel Behr commented, “Our two Series A investors, BASF Venture Capital and billionaire investor Hansjörg Wyss, are thrilled that we’ve successfully transitioned our breakthrough technologies out of the Harvard labs and into the marketplace.” Mr. Behr is a serial entrepreneur with particular expertise in commercializing innovations coming out of academia. “By the end of our first year of operation we had delivered alpha products to various customers,” Mr. Behr added. “Now we are positioned for broader commercial deployment through beta product launches and expansion of our strategic partnerships.”

SLIPS also announced that current Independent Director David Ward, a partner with MTI Ventures, has been appointed as Board Chairman. Mr. Ward said, “I have enjoyed working with the company since joining the board at the beginning of 2015 – it’s exciting to be involved with such a novel advanced materials platform technology that has virtually endless applications. I look forward to helping the business through its next growth phase.”

About SLIPS
SLIPS Technologies, Inc. makes fully-slippery materials and coatings that solve sticky surface problems in industrial, medical, and consumer applications. Our highly repellent surfaces can be created on any material to repel virtually all fluids and biological fouling agents. The patented SLIPS portfolio of pioneering and award-winning technologies was created at the Harvard John A. Paulson School of Engineering and Applied Sciences and the Wyss Institute for Biologically Inspired Engineering at Harvard University. SLIPS opened a new field in materials science in 2011 that has been adopted by various research teams worldwide. Learn more at www.slipstechnologies.com

For SLIPS Technologies, Inc.
Karen Sharma, 781-235-3060
ksharma@macbiocom.com